Ocular Therapeutix (OCUL) Change in Inventory (2014 - 2026)
Ocular Therapeutix (OCUL) posted quarterly Change in Inventory of $89000.0 for Q2 2026, up 138.7% year-over-year from $37286.0 in Q2 2025, and down 48.55% on a QoQ basis from $173000.0 in Q1 2026.
Ocular Therapeutix (OCUL) Change in Inventory (2014 - 2026) Analysis & Trends
Ocular Therapeutix has reported Change in Inventory for 13 years, with the latest figure at $89000.0 in Q2 2026.
- Change in Inventory for Q2 2026 came in at $89000.0, up 138.7% year-over-year; the trailing twelve-month figure through Jun 2026 was $787000.0 (up 59.96% YoY), and the FY2025 annual result was $524000.0, down 28.71% from the prior year.
- Change in Inventory eased to $89000.0 in Q2 2026, from $173000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $635000.0 in Q4 2024 and troughed at -$230000.0 in Q2 2025.
- A 5-year average of $143111.1 and a median of $98500.0 in 2022 frame the typical range for Change in Inventory.
- The widest annual swing landed in 2022, when Change in Inventory soared 1432.14%; it then tumbled 751.85% in 2025.
- A 5-year view of Change in Inventory shows it stood at $429000.0 in 2022, then tumbled by 88.81% to $48000.0 in 2023, then soared by 1222.92% to $635000.0 in 2024, then sank by 88.03% to $76000.0 in 2025, then rose by 17.11% to $89000.0 in 2026.
- Per Business Quant data, the three most recent Change in Inventory figures were $89000.0 in Q2 2026, $173000.0 in Q1 2026, and $76000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Ocular Therapeutix | 2.20 Bn | 2.20 Bn | 11.46 Mn | 89,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 89,000.00 |
| Jun 30, 2026 | 89,000.00 |
| Mar 31, 2026 | 173,000.00 |
| Mar 31, 2026 | 173,000.00 |
| Dec 31, 2025 | 76,000.00 |
| Dec 31, 2025 | 76,000.00 |
| Sep 30, 2025 | 449,000.00 |
| Sep 30, 2025 | 449,000.00 |
| Jun 30, 2025 | -230,000.00 |
| Jun 30, 2025 | -230,000.00 |
| Mar 31, 2025 | 229,000.00 |
| Mar 31, 2025 | 229,000.00 |
| Dec 31, 2024 | 635,000.00 |
| Dec 31, 2024 | 635,000.00 |
| Sep 30, 2024 | -142,000.00 |
| Sep 30, 2024 | -142,000.00 |
| Jun 30, 2024 | -27,000.00 |
| Jun 30, 2024 | -27,000.00 |
| Mar 31, 2024 | 269,000.00 |
| Mar 31, 2024 | 269,000.00 |